Efficacy of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis

Exclusion Criteria

• •Patients with arthritis or ankylosing spondyitis
• •Drug-induced psoriasis
• •Male or female patients who plan to conceive during the time course of the study, or for 6 months after the administration of the second dose.
• •Participation in any clinical trial within 4 weeks prior to initial dosing or longer.
• •Previous use of immunosuppressive agents eg cyclosporine, without the necessary wash-out period
• •History of severe allergy to food or drugs